These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 31889628

  • 1. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C, Dowhan M, Dabas R, Chaudhry A, Kalra A, Dharmani-Khan P, Gregson D, Johnson A, Jupp J, Jimenez-Zepeda V, Jamani K, Duggan P, Tay J, Khan F, Daly A, Storek J.
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [Abstract] [Full Text] [Related]

  • 2. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
    Diri R, Anwer F, Yeager A, Krishnadasan R, McBride A.
    Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
    [Abstract] [Full Text] [Related]

  • 3. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D, Hirzel C, Boely E, Lecompte T, Khanna N, Mueller NJ, Boggian K, Cusini A, Manuel O, van Delden C, Swiss Transplant Cohort Study.
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [Abstract] [Full Text] [Related]

  • 4. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF, Pisasale D, Wight J, Trubiano JA.
    Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA, Ison MG, Angarone MP, Yang A, Stosor V.
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
    McCollam S, Lewis JS, Bubalo J, Diaz A.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0083322. PubMed ID: 36214573
    [Abstract] [Full Text] [Related]

  • 9. Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation.
    Lipsitt A, Hijano DR, Ferrolino JA, Dallas R, Sharma A, Maron G.
    Pediatr Blood Cancer; 2024 Oct 15; 71(10):e31201. PubMed ID: 39010649
    [Abstract] [Full Text] [Related]

  • 10. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ, Naylor SM, Roecker AM.
    Ann Pharmacother; 2016 Aug 15; 50(8):673-9. PubMed ID: 27242349
    [Abstract] [Full Text] [Related]

  • 11. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, Ota Y.
    J Infect Chemother; 2019 May 15; 25(5):351-354. PubMed ID: 30711257
    [Abstract] [Full Text] [Related]

  • 12. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Molina A, Winston DJ, Pan D, Schiller GJ.
    Biol Blood Marrow Transplant; 2018 Aug 15; 24(8):1715-1720. PubMed ID: 29555315
    [Abstract] [Full Text] [Related]

  • 13. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE, Cuyx S, Dejagere T, van der Hilst JC.
    Transpl Infect Dis; 2017 Apr 15; 19(2):. PubMed ID: 28035717
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF, Elshinawy M, AlRawas A, Khater D, Zadjaly S, Wali Y.
    J Pediatr Hematol Oncol; 2017 Apr 15; 39(3):203-208. PubMed ID: 28234744
    [Abstract] [Full Text] [Related]

  • 15. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P, Zhu X, Liang W, Cai R.
    Mycoses; 2021 May 15; 64(5):495-502. PubMed ID: 33368732
    [Abstract] [Full Text] [Related]

  • 16. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
    Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
    J Int AIDS Soc; 2021 Jun 15; 24(6):e25726. PubMed ID: 34118121
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
    Awad WB, Asaad A, Al-Yasein N, Najjar R.
    BMC Infect Dis; 2020 Jun 05; 20(1):400. PubMed ID: 32503449
    [Abstract] [Full Text] [Related]

  • 18. Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors.
    Arnold LM, Hoshina Y, Lee H, Colman H, Mendez J.
    J Neurooncol; 2024 Mar 05; 167(1):211-217. PubMed ID: 38363493
    [Abstract] [Full Text] [Related]

  • 19. Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review.
    Kostakis ID, Sotiropoulos GC, Kouraklis G.
    Transplant Proc; 2014 Nov 05; 46(9):3206-8. PubMed ID: 25420860
    [Abstract] [Full Text] [Related]

  • 20. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.
    Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D.
    Chest; 2020 Dec 05; 158(6):2323-2332. PubMed ID: 32502592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.